Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: A multi-state report

American Journal of Infection Control

Volumn 39, Issue 6, 2011, Pages 521-524

  Chemaly, Roy F ^a   Rathod, Dhanesh B ^a   Sikka, Monica K ^b   Hayden, Mary K ^b   Hutchins, Mark ^c   Horn, Tracy ^c   Tarrand, Jeffery ^a   Adachi, Javier ^a   Nguyen, Kim ^a   Trenholme, Gorden ^b   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Nebraska Hematology Oncology PC   (United States)

Author keywords

contaminated devices; hospital related infection; multi state outbreak; Serratia marcescens bacteremia

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN; SODIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CONTAMINATION; CHILD; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SCHOOL CHILD; SERRATIA MARCESCENS; SYRINGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; DRUG CONTAMINATION; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; SERRATIA INFECTIONS; SERRATIA MARCESCENS; SODIUM CHLORIDE; SYRINGES; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 79960942431     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.08.020     Document Type: Article

References (15)

1. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997;24:1068-78.
2. Martone WJ, Gaynes RP, Horan TC, Danzig L, Emori TG, Monnet D, et al. National Nosocomial Infections Surveillance (NNIS) semiannual report, May 1995: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1995;23:377-85.
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
4. Vigeant P, Loo VG, Bertrand C, Dixon C, Hollis R, Pfaller MA, et al. An outbreak of Serratia marcescens infections related to contaminated chlorhexidine. Infect Control Hosp Epidemiol 1998;19:791-4.
5. Archibald LK, Corl A, Shah B, Schulte M, Arduino MJ, Aguero S, et al. Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap. Infect Control Hosp Epidemiol 1997;18: 704-9.
6. Beck-Sague CM, Jarvis WR. Epidemic bloodstream infections associated with pressure transducers: a persistent problem. Infect Control Hosp Epidemiol 1989;10:54-9.
7. Vandenbroucke-Grauls CM, Baars AC, Visser MR, Hulstaert PF, Verhoef J. An outbreak of Serratia marcescens traced to a contaminated bronchoscope. J Hosp Infect 1993;23:263-70.
8. Grohskopf LA, Roth VR, Feikin DR, Arduino MJ, Carson LA, Tokars JI, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001;344: 1491-7.
9. Blossom D, Noble-Wang J, Su J, Pur S, Chemaly R, Shams A, et al. Serratia in Prefilled Syringes Investigation Team Group. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. Arch Intern Med 2009;169:1705-11.
10. Su JR, Blossom DB, ChungW, Gullion JS, Pascoe N, Heseltine G, et al. Epidemiologic investigation of a 2007 outbreak of Serratia marcescens bloodstream infection in Texas caused by contamination of syringes prefilled with heparin and saline. Infect Control Hosp Epidemiol 2009;30:593-5.
11. Food and Drug Administration. Recall-Firm press release. Available from: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2007/ ucm112333.htm. Accessed February 15, 2010.
12. Chemaly RF, Rathod DB, Raad II. A tertiary care cancer center experience of the 2007 outbreak of Serratia marcescens bloodstream infection due to prefilled syringes. Infect Control Hosp Epidemiol 2009;30: 1237-8.
13. Food and Drug Administration. Recall-Firm press release. Available from: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ ucm112343.htm. Accessed February 15, 2010.
14. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 2005;55:90-4.
15. Sunenshine RH, Tan ET, Terashita DM, Jensen BJ, Kacica MA, Sickbert- Bennett EE, et al. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clin Infect Dis 2007;45: 527-33.